Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.Journal of the Neurological Sciences|August 7, 2009
Gender differences in multiple sclerosis: cytokines and vitamin DM J Eikelenboom, J Killestein, J J Kragt, et al.Multiple Sclerosis and Related Disorders|November 16, 2019
Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision makingC E P van Munster, L Kaya, K H Lam, et al.Multiple Sclerosis and Related Disorders|February 12, 2026
Aging does not affect the relationship between OCT and clinical or MRI outcome measuresS Kaçar, Julia R Jelgerhuis, J Killestein, et al.Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.Journal of Neuroimmunology|April 2, 2003
Immunomodulatory effects of orally administered cannabinoids in multiple sclerosisJ Killestein, E L J Hoogervorst, M Reif, et al.Journal of Neuroimmunology|November 26, 2002
Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-betaJ Killestein, R Q Hintzen, B M J Uitdehaag, et al.European Journal of Neurology|March 29, 2016
High cumulative JC virus seroconversion rate during long-term use of natalizumabA Vennegoor, J A van Rossum, C Leurs, et al.Journal of Neuroimmunology|November 26, 2002
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosisM J Eikelenboom, J Killestein, T Izeboud, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2014
A dam for retrograde axonal degeneration in multiple sclerosis?L J Balk, J W R Twisk, M D Steenwijk, et al.Pageof 17